Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
mitotane (lysodren) (3 trials)
recombinant human tumor necrosis factor receptor ii -fc-tpo mimetic peptide fusion protein (1 trial)
Ascites (Phase 1)
Carcinoma (Phase 1)
Peritoneal Neoplasms (Phase 1)
Pleural Effusion (Phase 1)
Pleural Effusion, Malignant (Phase 1)
Trials (4 total)
Trial APIs (2 total)